TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32236530

Group type: EXPERIMENTAL
Intervention: Intervention group (educational session for GPs, mouse pad reminder, poster in waiting rooms)
Number of subjects: 10360

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 10360

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 10360
Study: 35189943

Group type: EXPERIMENTAL
Intervention: TLC599 12 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: TLC599 18 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 34496979

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg/week plus Methotrexate (MTX)
Number of subjects: 281
Study: 35632774

Group type: EXPERIMENTAL
Intervention: STX-3 (3 times/day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: STX-5 (5 times/day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: STX-3 (3 times/day) with baseline cycle threshold values of 20–30
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (standard therapy only)
Number of subjects: 57
Study: 34287644

Group type: EXPERIMENTAL
Intervention: Born SGA
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control
Number of subjects: 158
Study: 34613513

Group type: EXPERIMENTAL
Intervention: Osmotic Release Oral System (OROS) Methylphenidate (MPH)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 34310432

Group type: EXPERIMENTAL
Intervention: Tolcapone for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 20
Study: 32066605

Group type: EXPERIMENTAL
Intervention: Brief support for self-management of weight during child immunisation appointments, including weekly self-weighing and use of an online weight management programme.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Usual care plus the intervention (brief support).
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care only (healthy lifestyle leaflet).
Number of subjects: 80
Study: 616850836

Group type: EXPERIMENTAL
Intervention: 30 mg genistein daily for 3-6 weeks before prostatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo capsules daily for 3-6 weeks before prostatectomy
Number of subjects: 0
Study: 35871424

Group type: EXPERIMENTAL
Intervention: Video modeling based tooth-brushing education
Number of subjects: 137

Group type: COMPARATOR
Intervention: Social story based tooth-brushing education
Number of subjects: 137
Study: 34048966

Group type: EXPERIMENTAL
Intervention: Prediction model for postpartum hemorrhage based on antenatal and intrapartum risk factors
Number of subjects: 9774

Group type: EXPERIMENTAL
Intervention: Prediction model applied to validation cohort
Number of subjects: 9774
Study: 34606166

Group type: EXPERIMENTAL
Intervention: Hierarchical, diversified nursing soft skills training
Number of subjects: 124

Group type: COMPARATOR
Intervention: Conventional nursing training
Number of subjects: 124
Study: 33338070

Group type: EXPERIMENTAL
Intervention: Spontaneous interaction context (storytime session)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Nonspontaneous interaction context (assistant bouncing infant in synchrony with a stranger)
Number of subjects: 43
Study: 36382431

Group type: EXPERIMENTAL
Intervention: Rectal midazolam (0.3 mg/kg, max 15 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine practice with no sedation
Number of subjects: 84
Study: 32133486

Group type: EXPERIMENTAL
Intervention: Retention group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Non-retention group
Number of subjects: 63
Study: 34300168

Group type: EXPERIMENTAL
Intervention: Version 1 (nicotine)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Version 2 (nicotine, on its own)
Number of subjects: 926
Study: 36335684

Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg/day)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451
Study: 34254233

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Sham EA
Number of subjects: 448
Study: 35241135

Group type: EXPERIMENTAL
Intervention: Neostigmine (1 mg every 12 hours, increased to every 8 hours or every 6 hours depending on response)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 80
Study: 32551853

Group type: EXPERIMENTAL
Intervention: S-1 maintenance therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 33136254

Group type: EXPERIMENTAL
Intervention: Individual Intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Caregiver‐assisted Intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 78
Study: 33899682

Group type: EXPERIMENTAL
Intervention: Self‐ vs. other‐oriented benefits
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Short‐ vs. long‐term benefits
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Acknowledgment of disadvantages: yes vs. no
Number of subjects: 521

Group type: COMPARATOR
Intervention: No-message control condition
Number of subjects: 521
Study: 36418088

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB) with glenohumeral joint (GHJ) injection and physiotherapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo with glenohumeral joint (GHJ) injection and physiotherapy
Number of subjects: 54
Study: 33272319

Group type: EXPERIMENTAL
Intervention: Helmet continuous positive airway pressure (CPAP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 120
Study: 34303786

Group type: EXPERIMENTAL
Intervention: Micronutrients (vitamins/minerals)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 32882100

Group type: EXPERIMENTAL
Intervention: PD01A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PD03A
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34585554

Group type: EXPERIMENTAL
Intervention: Optimal medical therapy (OMT)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: High-intensity statin therapy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: LDL-C < 70 mg/dl
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure < 140 mm Hg
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Not smoking
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Aspirin therapy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: ACEI / ARB therapy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 333
Study: 34330312

Group type: EXPERIMENTAL
Intervention: Ellagic acid (200 mg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33034419

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cutting balloon angioplasty (CBA)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both RA and CBA
Number of subjects: 71
Study: 35255819

Group type: EXPERIMENTAL
Intervention: Quadruple therapy plus S. boulardii (Group S)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Quadruple therapy plus L. reuteri (Group P)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Group S (S. boulardii)
Number of subjects: 156
Study: 34334635

Group type: EXPERIMENTAL
Intervention: Hypothermic oxygenated machine perfusion (HOPE)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Static cold storage (SCS)
Number of subjects: 46
Study: 33039810

Group type: EXPERIMENTAL
Intervention: Urea cream
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 288
Study: 36201678

Group type: EXPERIMENTAL
Intervention: Informational intervention emphasizing evidence-based harm reduction and treatment programs
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 284
Study: 34292261

Group type: EXPERIMENTAL
Intervention: Treadmill-based high-intensity interval exercise (TMHIIE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cycle ergometer high-intensity interval exercise (CEHIIE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Treadmill moderate-intensity continuous exercise (TMMICE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cycle ergometer moderate-intensity continuous exercise (CEMICE)
Number of subjects: 12
Study: 35691460

Group type: EXPERIMENTAL
Intervention: PBRM (15 mg/kg orally by gavage)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 33890242

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 10743

Group type: COMPARATOR
Intervention: Enoxaparin followed by warfarin
Number of subjects: 10743
Study: 32075571

Group type: EXPERIMENTAL
Intervention: Intraventricular alteplase
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Primary intraventricular hemorrhage patients (combined treatment groups)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Primary intraventricular hemorrhage patients
Number of subjects: 46
Study: 33387347

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) applied biannually
Number of subjects: 79

Group type: COMPARATOR
Intervention: Alternative restorative technique (ART)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF)
Number of subjects: 79
Study: 32428974

Group type: EXPERIMENTAL
Intervention: Shigellosis (Shigella species)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: S. flexneri
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: S. flexneri 6
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: S. sonnei
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Norovirus
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Fever
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Loss of consciousness
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: WHZ at enrollment
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Follow-up anthropometrics
Number of subjects: 192
Study: 35785538

Group type: EXPERIMENTAL
Intervention: HEPA air cleaners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbon filter air cleaners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34407025

Group type: EXPERIMENTAL
Intervention: Integrated yoga therapy (asanas and pranayama) from 18 to 22 weeks of gestation until delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine standard care
Number of subjects: 0
Study: 32759258

Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg two times per day
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 35180569

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (medication review, health education, adherence aids, seizure registration, therapeutic drug monitoring)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 182

Group type: COMPARATOR
Intervention: Pharmaceutical care program vs. Usual care
Number of subjects: 182
Study: 34976813

Group type: EXPERIMENTAL
Intervention: Single-agent sodium cantharidinate (SCA)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Single-agent docetaxel (DOX)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Docetaxel/sodium cantharidinate combination (CON)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (single-agent SCA and single-agent DOX)
Number of subjects: 148
Study: 32168176

Group type: EXPERIMENTAL
Intervention: Concentric exercise
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Leg extension exercise
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Isometric peak torque
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Muscle soreness
Number of subjects: 23
Study: 35669097

Group type: EXPERIMENTAL
Intervention: DMPA‐IM
Number of subjects: 2911

Group type: COMPARATOR
Intervention: NET‐EN
Number of subjects: 2911
Study: 35844809

Group type: EXPERIMENTAL
Intervention: Sublingual sufentanil 30 mcg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intravenous fentanyl 50 mcg
Number of subjects: 75
Study: 32614201

Group type: EXPERIMENTAL
Intervention: Proactive outreach
Number of subjects: 1938

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1938
Study: 35982781

Group type: EXPERIMENTAL
Intervention: Nomogram based on 7 independent risk factors (age, diabetes history, gallbladder wall thickness, gallstone diameter, coexisting common bile duct stones, direct bilirubin, white blood cell count)
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Nomogram in validation cohort
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Calibration curve
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA) and clinical impact curve (CIC)
Number of subjects: 816
Study: 32756180

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF), 24 hours continuous treatment, n = 21
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (without HVHF), n = 21
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-survival group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acute physiology and chronic health evaluation I score and IL-6 level
Number of subjects: 42
Study: 34965499

Group type: EXPERIMENTAL
Intervention: Protein-enhanced diet using mealworms
Number of subjects: 216

Group type: COMPARATOR
Intervention: Grain powder (control)
Number of subjects: 216
Study: 34181876

Group type: COMPARATOR
Intervention: Baseline FeNO <25 ppb (n=291)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Baseline FeNO 25 to <50 ppb (n=185)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Baseline FeNO ≥50 ppb (n=144)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Baseline FeNO ≥25 ppb and blood eosinophil count ≥150 cells per μL and two or more prior exacerbations (n=157)
Number of subjects: 620
Study: 35969887

Group type: EXPERIMENTAL
Intervention: Low-dose 17β estradiol (n = 72)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo (n = 99)
Number of subjects: 171
Study: 34117493

Group type: EXPERIMENTAL
Intervention: Informatics intervention for IDH prevention
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Design principles for informatics intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pragmatic cluster-randomized controlled trial
Number of subjects: 45
Study: 35550053

Group type: EXPERIMENTAL
Intervention: Once‐only colonoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two rounds of faecal immunochemical testing 2 years apart
Number of subjects: 0
Study: 32103495

Group type: EXPERIMENTAL
Intervention: ω‐3 PUFA + ASA (3 g of fish oil/d + 100 mg ASA/d for 2 months) after periodontal debridement (TG1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ω‐3 PUFA + ASA (3 g of fish oil/d + 100 mg ASA/d for 2 months) before periodontal debridement (TG2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo and periodontal debridement (CG)
Number of subjects: 75
Study: 33389135

Group type: EXPERIMENTAL
Intervention: Sodium chloride (salt) water-based mouth rinse (test group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: 0.12% chlorhexidine mouth rinse (control group)
Number of subjects: 47
Study: 33201927

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfers (UCTs) + package of community activities
Number of subjects: 2658
Study: 36106652

Group type: EXPERIMENTAL
Intervention: Insulin icodec (once-weekly basal insulin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine U100 or U300 or insulin degludec (comparator treatments)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin icodec
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine U100 or U300 or insulin degludec
Number of subjects: 0
Study: 33464335

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy alone
Number of subjects: 234

Group type: COMPARATOR
Intervention: Intravenous alteplase plus endovascular thrombectomy
Number of subjects: 234
Study: 32383767

Group type: EXPERIMENTAL
Intervention: Oral probiotic capsules containing Lactobacillus paracasei LPC‐S01 (24 billion CFU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 40
Study: 34877254

Group type: EXPERIMENTAL
Intervention: Bo's abdominal acupuncture (BAA) combined with rehabilitation training (RT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rehabilitation training (RT)
Number of subjects: 50
Study: 35410411

Group type: EXPERIMENTAL
Intervention: Cervitec F (CF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Duraphate (DP)
Number of subjects: 20
Study: 32712606

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (4 sessions over 4-6 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 48
Study: 32718555

Group type: EXPERIMENTAL
Intervention: Complete Revascularization (CR)
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Incomplete Revascularization (IR)
Number of subjects: 1276
Study: 36482786

Group type: EXPERIMENTAL
Intervention: 10 mg/kg acetaminophen
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 mg/kg acetaminophen
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 mg/kg acetaminophen
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Haematology and biochemistry profiles
Number of subjects: 6
Study: 34001849

Group type: EXPERIMENTAL
Intervention: meplazumab
Number of subjects: 59
Study: 32469182

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (6.4 mg/kg every 3 weeks)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Chemotherapy (physician's choice, 55 received irinotecan and 7 paclitaxel)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 187

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 187
Study: 35272017

Group type: EXPERIMENTAL
Intervention: Vitamin D (100,000 IU monthly)
Number of subjects: 779

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 779
Study: 33887451

Group type: EXPERIMENTAL
Intervention: CIED-derived patient activity (highest quintile, Q5)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: CIED-derived patient activity (lowest quintile, Q1)
Number of subjects: 1500
Study: 32620335

Group type: EXPERIMENTAL
Intervention: Probiotics (1 × 10^9 CFU/day, 2 capsules, tid) for 2 months
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 116
Study: 33926511

Group type: EXPERIMENTAL
Intervention: Real Acupuncture (RA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy Control (HC)
Number of subjects: 48
Study: 32102507

Group type: EXPERIMENTAL
Intervention: Serological noninvasive screening and treatment for atrophic gastritis
Number of subjects: 2847

Group type: COMPARATOR
Intervention: Noninvasive serologic screening
Number of subjects: 2847

Group type: EXPERIMENTAL
Intervention: Histopathology tests and noninvasive serologic screening
Number of subjects: 2847
Study: 36244364

Group type: EXPERIMENTAL
Intervention: Risdiplam (0.2 mg/kg for infants 5 months to 2 years, adjusted for younger infants)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Risdiplam
Number of subjects: 41
Study: 33775110

Group type: EXPERIMENTAL
Intervention: Prior HF hospitalization within 12 months
Number of subjects: 4205

Group type: EXPERIMENTAL
Intervention: Prior HF hospitalization 0-4 months before index hospitalization
Number of subjects: 4205

Group type: EXPERIMENTAL
Intervention: Prior HF hospitalization 4-8 months before index hospitalization
Number of subjects: 4205

Group type: EXPERIMENTAL
Intervention: Prior HF hospitalization 8-12 months before index hospitalization
Number of subjects: 4205

Group type: EXPERIMENTAL
Intervention: Prior HF hospitalization more than 12 months before index hospitalization
Number of subjects: 4205
Study: 33237229

Group type: EXPERIMENTAL
Intervention: Sealer 26
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 54
Study: 33922929

Group type: EXPERIMENTAL
Intervention: Team emotional management intervention designed to help detect and manage emotions during virtual teamwork
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control condition (with no intervention)
Number of subjects: 102
Study: 32371432

Group type: EXPERIMENTAL
Intervention: Concordant to disease activity cluster
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Dominant fatigue cluster
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Dominant pain and fatigue cluster
Number of subjects: 140

Group type: COMPARATOR
Intervention: Concordant cluster vs Dominant pain and fatigue cluster
Number of subjects: 140

Group type: COMPARATOR
Intervention: Concordant cluster vs Dominant fatigue cluster
Number of subjects: 140

Group type: COMPARATOR
Intervention: Other PROs
Number of subjects: 140
Study: 32045540

Group type: EXPERIMENTAL
Intervention: New clinical V̇O2 peak equation from 6MWT: V̇O2 peak (mL.kg‐1.min‐1) = (‐0.283*age(years)) ‐ (0.099*weight(kg)) + (0.071*6MWD(meters)) ‐(0.135*HR end(bpm)) + 22.789
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: New disease-specific V̇O2 peak equation from 6MWT: V̇O2 peak (mL.kg‐1.min‐1) = (‐0.236*age(years)) ‐ (0.094*weight(kg)) ‐(0.120*HR end(bpm)) + (0.067*6MWD(meters)) + (0.065*MVLPA(min/day)) ‐ (0.204*DT(years)) + 25.145
Number of subjects: 200
Study: 32852275

Group type: EXPERIMENTAL
Intervention: Bayesian methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statistical significance testing
Number of subjects: 0
Study: 34275774

Group type: EXPERIMENTAL
Intervention: Drug holiday from 1 month before to 3 months after surgical tooth extraction
Number of subjects: 23

Group type: COMPARATOR
Intervention: Drug continuation
Number of subjects: 23
Study: 33848565

Group type: EXPERIMENTAL
Intervention: Structured, moderate-intensity physical activity intervention (PA)
Number of subjects: 1535

Group type: COMPARATOR
Intervention: Health education program (HE)
Number of subjects: 1535
Study: 34853162

Group type: EXPERIMENTAL
Intervention: CLO view
Number of subjects: 100

Group type: COMPARATOR
Intervention: LAT view
Number of subjects: 100